BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27705010)

  • 1. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria.
    Fox CM; Boliek CA
    J Speech Lang Hear Res; 2012 Jun; 55(3):930-45. PubMed ID: 22232407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT
    Ertan E; Gürvit HI; Hanağası HH; Bilgiç B; Tunçer MA; Yılmaz C
    Logoped Phoniatr Vocol; 2022 Dec; 47(4):262-270. PubMed ID: 34287100
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study.
    Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA
    J Commun Disord; 2020; 86():106003. PubMed ID: 32505858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of speech cues in French-speaking children with dysarthria.
    Levy ES; Moya-Galé G; Chang YM; Campanelli L; MacLeod AAN; Escorial S; Maillart C
    Int J Lang Commun Disord; 2020 May; 55(3):401-416. PubMed ID: 32077196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic Predictors of Pediatric Dysarthria in Cerebral Palsy.
    Allison KM; Hustad KC
    J Speech Lang Hear Res; 2018 Mar; 61(3):462-478. PubMed ID: 29466556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual and environmental contributions to treatment outcomes following a neuroplasticity-principled speech treatment (LSVT LOUD) in children with dysarthria secondary to cerebral palsy: a case study review.
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2014 Aug; 16(4):372-85. PubMed ID: 25011399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in White Matter Integrity following Intensive Voice Treatment (LSVT LOUD®) in Children with Cerebral Palsy and Motor Speech Disorders.
    Reed A; Cummine J; Bakhtiari R; Fox CM; Boliek CA
    Dev Neurosci; 2017; 39(6):460-471. PubMed ID: 28750368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
    Wenke RJ; Cornwell P; Theodoros DG
    Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptual and Acoustic Effects of Dual-Focus Speech Treatment in Children With Dysarthria.
    Levy ES; Chang YM; Hwang K; McAuliffe MJ
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2301-2316. PubMed ID: 33656916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acoustic-phonetic contrasts and intelligibility in the dysarthria associated with mixed cerebral palsy.
    Ansel BM; Kent RD
    J Speech Hear Res; 1992 Apr; 35(2):296-308. PubMed ID: 1573870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive Voice Treatment (Lee Silverman Voice Treatment [LSVT LOUD]) for Children With Down Syndrome: Phase I Outcomes.
    Boliek CA; Halpern A; Hernandez K; Fox CM; Ramig L
    J Speech Lang Hear Res; 2022 Apr; 65(4):1228-1262. PubMed ID: 35230877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic and Perceptual Consequences of Speech Cues for Children With Dysarthria.
    Levy ES; Chang YM; Ancelle JA; McAuliffe MJ
    J Speech Lang Hear Res; 2017 Jun; 60(6S):1766-1779. PubMed ID: 28655046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.